Frequency, clinical presentation and outcome of vigilance impairment in patients with uni- and bilateral ischemic infarction of the paramedian thalamus.


Journal

Journal of neurology
ISSN: 1432-1459
Titre abrégé: J Neurol
Pays: Germany
ID NLM: 0423161

Informations de publication

Date de publication:
Nov 2021
Historique:
received: 25 11 2020
accepted: 15 04 2021
revised: 13 04 2021
pubmed: 22 4 2021
medline: 14 10 2021
entrez: 21 4 2021
Statut: ppublish

Résumé

Ischemic stroke of the paramedian thalamus is a rare differential diagnosis in sudden altered vigilance states. While efforts to describe clinical symptomatology exist, data on the frequency of paramedian thalamic stroke as a cause of sudden impaired vigilance and on accompanying clinical signs and outcome are scarce. We retrospectively analyzed consecutive patients admitted to a tertiary stroke center between 2010 and 2019 diagnosed with paramedian thalamic stroke. We evaluated frequency of vigilance impairment (VI) due to paramedian thalamic stroke, accompanying clinical signs and short-term outcome in uni- versus bilateral paramedian lesion location. Of 3896 ischemic stroke patients, 53 showed a paramedian thalamic stroke location (1.4%). VI was seen in 29/53 patients with paramedian thalamic stroke and in 414/3896 with any stroke (10.6%). Paramedian thalamic stroke was identified as causal to VI in 3.4% of all patients with initial VI in the emergency department and in 0.7% of all ischemic stroke patients treated in our center. Accompanying clinical signs were detected in 21 of these 29 patients (72.4%) and facilitated a timely diagnosis. VI was significantly more common after bilateral than unilateral lesions (92.0% vs. 21.4%; p < 0.001). Patients with bilateral paramedian lesions were more severely affected, had longer hospital stays and more frequently required in-patient rehabilitation. Paramedian thalamic lesions account for about 1 in 15 stroke patients presenting with impaired vigilance. Bilateral paramedian lesion location is associated with worse stroke severity and short-term outcome. Paying attention to accompanying clinical signs is of importance as they may facilitate a timely diagnosis.

Identifiants

pubmed: 33881597
doi: 10.1007/s00415-021-10565-y
pii: 10.1007/s00415-021-10565-y
pmc: PMC8505279
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

4340-4348

Informations de copyright

© 2021. The Author(s).

Références

Nervenarzt. 2011 Feb;82(2):231-41
pubmed: 21165588
J Stroke Cerebrovasc Dis. 2014 May-Jun;23(5):1083-8
pubmed: 24144596
Electroencephalogr Clin Neurophysiol. 1949 Nov;1(4):455-73
pubmed: 18421835
Lancet. 1974 Jul 13;2(7872):81-4
pubmed: 4136544
Science. 2018 Oct 26;362(6413):429-434
pubmed: 30361367
Neurology. 2015 Aug 11;85(6):505-11
pubmed: 26180146
J Med Case Rep. 2011 Oct 31;5:535
pubmed: 22040522
Science. 1993 Oct 29;262(5134):679-85
pubmed: 8235588
Eur Radiol. 2004 Sep;14(9):1615-26
pubmed: 15106015
Neurology. 2006 Jun 27;66(12):1817-23
pubmed: 16801643
Neurology. 1980 Jan;30(1):72-9
pubmed: 7188637
Ann Neurol. 1987 Feb;21(2):149-58
pubmed: 3827223
BMC Anesthesiol. 2015 Apr 29;15:65
pubmed: 25924678
Neurocrit Care. 2014 Jun;20(3):494-501
pubmed: 24566980
Annu Rev Neurosci. 1997;20:185-215
pubmed: 9056712
Eur Neurol. 2017;77(3-4):197-200
pubmed: 28190011
Neurology. 1988 Jun;38(6):837-48
pubmed: 3368064
Stroke. 2003 Sep;34(9):2264-78
pubmed: 12933968
Neurosci Biobehav Rev. 2015 Jul;54:3-17
pubmed: 25479103
Scand J Trauma Resusc Emerg Med. 2019 Nov 7;27(1):101
pubmed: 31699128
Stroke. 1989 Jul;20(7):864-70
pubmed: 2749846
Stroke. 1993 Jan;24(1):35-41
pubmed: 7678184
J Neuroophthalmol. 2021 Mar 1;41(1):29-36
pubmed: 31851027
Acta Neurol Scand. 2001 Jan;103(1):35-42
pubmed: 11153886
BMC Neurol. 2009 Dec 08;9:60
pubmed: 19995432
Ann Acad Med Singap. 1999 Jul;28(4):569-71
pubmed: 10561773
Curr Treat Options Neurol. 2017 Feb;19(2):5
pubmed: 28251587

Auteurs

Merve Fritsch (M)

Department of Neurology, Charité Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin and Berlin Institute of Health, Charitéplatz 1, 10117, Berlin, Germany. merve.fritsch@charite.de.
Department of Psychiatry and Psychotherapy, CCM, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin and Berlin Institute of Health, Berlin, Germany. merve.fritsch@charite.de.

Kersten Villringer (K)

Center for Stroke Research Berlin, Charité Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin and Berlin Institute of Health, Berlin, Germany.

Ramanan Ganeshan (R)

Department of Neurology, Charité Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin and Berlin Institute of Health, Charitéplatz 1, 10117, Berlin, Germany.
Center for Stroke Research Berlin, Charité Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin and Berlin Institute of Health, Berlin, Germany.

Ida Rangus (I)

Department of Neurology, Charité Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin and Berlin Institute of Health, Charitéplatz 1, 10117, Berlin, Germany.
Center for Stroke Research Berlin, Charité Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin and Berlin Institute of Health, Berlin, Germany.

Christian H Nolte (CH)

Department of Neurology, Charité Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin and Berlin Institute of Health, Charitéplatz 1, 10117, Berlin, Germany.
Center for Stroke Research Berlin, Charité Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin and Berlin Institute of Health, Berlin, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH